Pasithea Therapeutics Corp. — Director's Dealing 2021

Oct 7, 2021

SEC Form 3/A — Form 3/A

Issuer: Pasithea Therapeutics Corp. (KTTA)
CIK: 0001841330
Period of Report: 2021-09-14

Reporting Person: Lazer Dean (Not a 10% owner)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	902600	Indirect

Footnotes

F1: This Form 3 was originally and incorrectly filed to disclose Dean Lazer as a 10% holder, specifically owning 902,600 shares of Common Stock through DPL Capital Inc. ("DPL"). Mr. Lazer is the President of DPL and has sole voting and investment control with respect to the shares held by DPL. As such, Mr. Lazer may be deemed to beneficially own the shares held directly by DPL. At this time, the 902,600 shares of Common Stock held by DPL represent less than 10% of the Common Stock. This amended Form 3/A discloses that Mr. Lazer is not a 10% holder.